With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

RubrYc has developed a unique molecular engineering approach to the discovery of epitope-selective antibodies. By combining greatly parallel in silico simulations, proprietary machine learning ...

Traditional antibody discovery procedures are often limited by the number of unique full-length antibodies that can be expressed and tested functionally or may deliver lead molecules that require ...